Karyopharm Therapeutics Inc. · NASDAQ:KPTI

Rangwala Reshma sold 449 Karyopharm Therapeutics Inc. shares (Form 4)

Traded Apr 21, 2026 · Filed Apr 22, 2026

On Apr 21, 2026, Rangwala Reshma (EVP & Chief Medical Officer) sold 449 Karyopharm Therapeutics Inc. shares at US$8.94 for US$4,014, leaving 56,290 shares. Filed Apr 22, 2026 (Form 4).

Sold
449 shares
Price
US$8.94
Value
US$4,014
Holding after
56,290 shares
Trading plan
No
Role
EVP & Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 21, 2026Common StockSale449US$8.9456,290Direct

Source

View original at SEC

Related